Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma
暂无分享,去创建一个
Ning Ma | Zhen Zong | Z. Hou | Enmin Huang | Tao Ma | Shuang Chen | Tai-Cheng Zhou | Jun-Yi Zhou | Wei-Sheng Yang | Chuang-Xiong Liu | Bing Zeng | Ying-Ru Li
[1] M. Nierengarten. Annual report to the nation on the status of cancer , 2022, Cancer.
[2] Xianwei Zhang,et al. A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma , 2022, Scientific Reports.
[3] Scott J. Dixon,et al. Copper-induced cell death , 2022, Science.
[4] T. Golub,et al. Copper induces cell death by targeting lipoylated TCA cycle proteins , 2022, Science.
[5] A. Casini,et al. Connecting copper and cancer: from transition metal signalling to metalloplasia , 2021, Nature Reviews Cancer.
[6] Jing Yang,et al. Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosis , 2021, Redox biology.
[7] L. Yao,et al. Identification of a prognostic ferroptosis-related lncRNA signature in the tumor microenvironment of lung adenocarcinoma , 2021, Cell death discovery.
[8] D. Chalopin,et al. Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies , 2021, Frontiers in Immunology.
[9] Ying Ma,et al. Differentially expressed lncRNAs in liver tissues of TX mice with hepatolenticular degeneration , 2021, Scientific Reports.
[10] Xing-gang Guo,et al. A nomogram for predicting the risk of postoperative recurrence of hepatitis B virus-related hepatocellular carcinoma in patients with high preoperative serum glutamyl transpeptidase. , 2021, Journal of gastrointestinal oncology.
[11] N. Cheng,et al. Inhibiting NLRP3 inflammasome activation prevents copper-induced neuropathology in a murine model of Wilson’s disease , 2021, Cell Death & Disease.
[12] Qiuran Xu,et al. Long noncoding RNA PICSAR/miR‐588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway , 2020, Cancer science.
[13] Philippe P Roux,et al. Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer , 2020, Nature Communications.
[14] Wei Hu,et al. Long noncoding RNA FOXD2‐AS1 aggravates hepatocellular carcinoma tumorigenesis by regulating the miR‐206/MAP3K1 axis , 2020, Cancer medicine.
[15] Weifeng He,et al. The role of long noncoding RNAs in hepatocellular carcinoma , 2020, Molecular Cancer.
[16] Y. Tao,et al. The epigenetic regulators and metabolic changes in ferroptosis-associated cancer progression , 2020, Molecular Cancer.
[17] G. Kroemer,et al. Activation of Autophagy, Observed in Liver Tissues From Patients With Wilson Disease and From ATP7B-Deficient Animals, Protects Hepatocytes From Copper-Induced Apoptosis. , 2019, Gastroenterology.
[18] Yassen Assenov,et al. Maftools: efficient and comprehensive analysis of somatic variants in cancer , 2018, Genome research.
[19] Herbert Yu,et al. A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53. , 2018, Cancer research.
[20] Wen-na Wang,et al. Effect of X-ray irradiation on hepatocarcinoma cells and erythrocytes in salvaged blood , 2017, Scientific Reports.
[21] Recinda L. Sherman,et al. Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival , 2017, Journal of the National Cancer Institute.
[22] Z. Trajanoski,et al. Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability. , 2016, Immunity.
[23] Ash A. Alizadeh,et al. Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.
[24] N. Hacohen,et al. Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity , 2015, Cell.
[25] J. Prieto,et al. A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C. , 2013, Journal of hepatology.
[26] R. Mumper,et al. Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. , 2009, Cancer treatment reviews.
[27] J. Fruehauf,et al. Reactive Oxygen Species: A Breath of Life or Death? , 2007, Clinical Cancer Research.
[28] M. Cronin,et al. Metals, toxicity and oxidative stress. , 2005, Current medicinal chemistry.
[29] D. Woodfield. Hepatocellular carcinoma. , 1986, The New Zealand medical journal.